Bortezomib 3.5mg Injection$51.00
1–9 boxes
$51.00 each
10–24 boxes
8% off
25+ boxes
10% off
Bortezomib 3.5mg Injection
SKU GME1363Oncology Care
Product Introduction
Bortezomib 3.5mg is a proteasome inhibitor for multiple myeloma and mantle-cell lymphoma. It is used alone or within a combination regimen selected for the disease and treatment stage.
How to use
The vial is prepared for subcutaneous or intravenous administration by the oncology team. Route-specific dilution is essential. It must never be given intrathecally. Doses are separated according to the treatment cycle.
How it works
Bortezomib inhibits the 26S proteasome, disrupting disposal of cellular proteins and triggering death of susceptible malignant cells.
Side effects
Peripheral neuropathy, low platelets, fatigue, nausea, diarrhoea, constipation and infection can occur. New weakness, severe breathlessness or marked bleeding needs urgent care.
Important information
Blood counts, neuropathy symptoms and blood pressure guide treatment adjustments. Herpes-zoster reactivation is a recognised risk, and antiviral prophylaxis is often included.
Uses
- Multiple myeloma and mantle-cell lymphoma.
Benefits
Suppressing malignant plasma or lymphoma cells can reduce disease burden and improve response to a combination treatment plan.
Why report tingling early?
Neuropathy can become harder to reverse if it progresses. Early symptoms may prompt a dose or schedule adjustment.
Can it cause dizziness when standing?
Postural hypotension can occur, particularly with dehydration or blood-pressure medicines.
Why might an antiviral be prescribed with it?
It reduces the risk of shingles reactivation during treatment.
Does the same vial concentration apply to both injection routes?
No. Subcutaneous and intravenous preparations can require different final concentrations, so route-specific preparation is essential.
Proteasome: a cellular protein-disposal complex. Multiple myeloma: cancer of plasma cells. Peripheral neuropathy: damage affecting nerves in the limbs.; AR: Bortezomib 3.5mg حقن; FR: Bortezomib 3.5mg injection; PT: Bortezomib 3.5mg injeção; ES: Bortezomib 3.5mg inyección; RU: Bortezomib 3.5mg инъекция; ID: Bortezomib 3.5mg suntikan; VI: Bortezomib 3.5mg thuốc tiêm; MS: Bortezomib 3.5mg suntikan; TL: Bortezomib 3.5mg iniksyon; ZH-SG: Bortezomib 3.5mg 注射剂